Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q3 2026 Earnings

11AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-2.85

-2.06

-1.26

-0.47

Details

Expected EPS

-0.548571

Actual EPS

-2.85

Surprise EPS

-2.3

Surprise Percent

+419.53%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -2.85 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.